WAYBRI

Serial Number 98812003
730

Registration Progress

Application Filed
Oct 21, 2024
Under Examination
Jul 8, 2025
Approved for Publication
May 13, 2025
Published for Opposition
May 13, 2025
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Jul 08, 2026 240 days

Trademark Image

WAYBRI

Basic Information

Serial Number
98812003
Filing Date
October 21, 2024
Published for Opposition
May 13, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jul 18, 2025
Application
Pending
Classes
005

Rights Holder

Edgewise Therapeutics, Inc.

03
Address
1715 38th Street
Boulder, CO 80301

Ownership History

Edgewise Therapeutics, Inc.

Original Applicant
03
Boulder, CO

Edgewise Therapeutics, Inc.

Owner at Publication
03
Boulder, CO

Legal Representation

Attorney
Aaron D. Hendelman

USPTO Deadlines

Next Deadline
240 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
July 08, 2026
Extension Available
Until July 08, 2026

Application History

15 events
Date Code Type Description Documents
Jul 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 18, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 18, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 18, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 8, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 13, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 13, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 7, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 3, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 3, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 3, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 21, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for the treatment of neuromuscular and cardiac disorders and diseases; anti-inflammatories

Classification

International Classes
005